Advertisement

Relationships between Stress and Brain 5-Hydroxytryptamine and Their Possible Significance in Affective Disorders

  • G. Curzon
Part of the Advances in Behavioral Biology book series (ABBI, volume 1)

Abstract

The work I will describe was prompted by the hope of eventually developing an animal model relevant to depressive illness. It is a truism that any animal model of a human affective disturbance suffers from a limitation imposed by the relative inability of animals to communicate with us, and this is compounded by our own tendency to anthropomorphize. Such limitations do not apply to the partial and less ambitious models in which biochemical abnormalities reported in the disturbance are simulated in animals. Here, however, the questions arise whether these abnormalities in man are in any way responsible for the disturbed mood or behavior, and whether the way in which the biochemical model is generated in the animal has etiological relevance.

Keywords

Plasma Cortisol Depressive Illness Tryptophan Metabolism Endogenous Depression Hydroxyanthranilic Acid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Azmitia, E. C., and McEwen, B. S. 1969. Corticosterone regulation of tryptophan hydroxylase in mid-brain of the rat. Science 166:1274.PubMedCrossRefGoogle Scholar
  2. Bridges, P. K.; and Jones, M. T. 1966. The diurnal rhythm of plasma cortisol concentration in depression. Brit. J. Psychiat. 112:1157.CrossRefGoogle Scholar
  3. Brody, J. F. 1970. Behavioural effects of serotonin depletion and of p-chlorophenylalanine (a serotonin depletor) in rats. Psychopharmacologia 17:14.PubMedCrossRefGoogle Scholar
  4. Brooksbank, B. W. L., and Coppen, A. 1967. Plasma 11-hydroxycor-ticoids in affective disorders. Brit. J. Psychiat. 113:395.PubMedCrossRefGoogle Scholar
  5. Bunney, W. E., and Davis, J. M. 1965. Norepinephrine in depressive reactions: A review. Arch. Gen. Psychiat. 13:483.PubMedCrossRefGoogle Scholar
  6. Butler, P. W. P., and Besser, G. M. 1968. Pituitary-adrenal function in severe depressive disease. Lancet 1:1234.PubMedCrossRefGoogle Scholar
  7. Carroll, B. J. 1969. Hypothalamic-pituitary function in depressive illness: Insensitivity to hypoglycaemia. Brit. Med. J. 3:27.PubMedCrossRefGoogle Scholar
  8. Clark, L. D.; Bauer, W.; and Cobb, S. 1952. Preliminary observations on mental disturbances occurring in patients under therapy with cortisone and ACTH. New Eng. J. Med. 246:205.PubMedCrossRefGoogle Scholar
  9. Cleghorn, R. A. 1951. Adrenal cortical insufficiency: psychologic cal and neurological observations. Canad. Med. Assoc. J. 65:449.PubMedGoogle Scholar
  10. Coppen, A.; Shaw, D. M.; Herzberg, B; and Maggs, R. 1967. Tryptophan in the treatment of depression. Lancet 2:1178.PubMedCrossRefGoogle Scholar
  11. Curzon, G.; and Bridges, P. K. 1970. Tryptophan metabolism in depression. J. Neurol. Neurosurg. Psychiat. 33:698.PubMedCrossRefGoogle Scholar
  12. Curzon, G., and Green, A. R. 1968. Effect of hydrocortisone on rat brain 5-hydroxytryptamine. Life Sci. 7:657.CrossRefGoogle Scholar
  13. Curzon, G.; and Green, A. R. 1969. Effects of immobilization on rat liver tryptophan pyrrolase and brain 5-hydroxytryptamine metabolism. Brit. J. Pharmacol. 37:689.Google Scholar
  14. Doig, R. J.; Mummery, R. V.; Wills, M. R., and Elkes, A. 1966. Plasma cortisol levels in depression. Brit. J. Psychiat. 112:1263.PubMedCrossRefGoogle Scholar
  15. Elithorn, A.; Bridges, P. K.; Hodges, J. R.; and Jones, M. T. 1969. Adrenocortical responsiveness during courses of electro-convulsive therapy. Brit. J. Psychiat. 115:575.PubMedCrossRefGoogle Scholar
  16. Fawcett, J. A., and Bunney, W. E. 1967. Pituitary adrenal function and depression. Arch. Gen. Psychiat. 16:517.PubMedCrossRefGoogle Scholar
  17. Fullerton, D. T.; Wenzel, F. J.; Lohrenz, F. N.; and Fahs, H. 1968a. Circadian rhythm of adrenal cortical activity in depression. I. A comparison of depressed patients with normal subjects. Arch. Gen. Psychiat. 19:674.PubMedCrossRefGoogle Scholar
  18. Fullerton, D. T.; Wenzel, F. J.; Lohrenz, F. N., and Fahs, H. 1968b. Circadian rhythm of adrenal cortical activity in depression. II. A comparison of types in depression. Arch. Gen. Psychiat. 19:682.PubMedCrossRefGoogle Scholar
  19. Green, A. R. 1969. Effects of hydrocortisone and stress on tryptophan metabolism. Ph.D. Thesis, University of London.Google Scholar
  20. Green, A. R.; and Curzon, G. 1968. Decrease of 5-hydroxytryptamine in the brain provoked by hydrocortisone and its prevention by allopurinol. Nature 220:1095.PubMedCrossRefGoogle Scholar
  21. Green, A. R., and Curzon, G. 1970. The effect of tryptophan metabolites on brain 5-hydroxytryptamine metabolism. Biochem. Pharmacol. 19:2061.PubMedCrossRefGoogle Scholar
  22. Green, A. R.; Joseph, M. G.; and Curzon, G. 1970. Oral contraceptives, depression and amino acid metabolism. Lancet 1:1288.PubMedCrossRefGoogle Scholar
  23. Hullin, R. P.; Bailey, A. D.; McDonald, R.; Dransfield, G. A.; and Milne, H. B. 1967. Variations in 11-hydroxycorticosteroids in depression and manic-depressive psychosis. Brit. J. Psychiat. 113:593.PubMedCrossRefGoogle Scholar
  24. Kim, J. H., and Miller, L. L. 1969. The functional significance of changes in activity of the enzymes, tryptophan pyrrolase and tyrosine transaminase, after induction in intact rats and in the isolated, perfused rat liver. J. Biol. Chem. 244:1410.PubMedGoogle Scholar
  25. Knapp, M. S.; Keane, P. M.; and Wright, J. G. 1967. Circadian rhythm of plasma 11-hydroxycorticoids in depressive illness, congestive heart failure, and Cushing’s syndrome. Brit. Med. J. 2:27.PubMedCrossRefGoogle Scholar
  26. Kostowski, W.; Giacalone, E.; Garattini, S.; and Valzelli, L. 1968. Studies on behavioural and biochemical changes in rats after lesion of mid-brain raphe. Europ. J. Pharmacol. 4:37.CrossRefGoogle Scholar
  27. Lewis, A. 1938. States of depression: their clinical and aetiologi-cal differentiation. Brit. Med. J. 2:875.PubMedCrossRefGoogle Scholar
  28. Liddle, G. W.; Island, D.; and Meador, C. K. 1962. Normal and abnormal regulation of corticotrophin secretion in man. Recent Progr. Hormone Res. 18:125.Google Scholar
  29. Maclean, R.; Nicholson, W. J.; Pare, C. M. B.; and Stacey, R. S. 1965. Effect of monoamine oxidase inhibitors on the concentration of 5-hydroxy-tryptamine in the human brain. Lancet 2:205.CrossRefGoogle Scholar
  30. McClure, D. J. 1966. The diurnal variation of plasma cortisol levels in depression. J. Psychosom. Res. 10:189.PubMedCrossRefGoogle Scholar
  31. McLeod, W. R.; Carroll, B. J.; and Davies, B. 1970. Hypothalamic dysfunction and antidepressant drugs. Brit. Med. J. 2:480.CrossRefGoogle Scholar
  32. Nistico, G., and Preziosi, P. 1969. Brain and liver tryptophan pathways and adrenocortical activation during restraint stress. Pharmacol. Res. Commun. 1:363.CrossRefGoogle Scholar
  33. Nistico, G., and Preziosi, P. 1970. Contraceptives, brain serotonin and liver tryptophan pyrrolase. Lancet 2:213.PubMedCrossRefGoogle Scholar
  34. Rubin, R. T., and Mandell, A. J. 1966. Adrenal cortical activity in pathological emotional states. Amer. J. Psychiat. 123:387.PubMedGoogle Scholar
  35. Sachar, E. J. 1967. Corticosteroids in depressive illness. I. A reevaluation of control issues and the literature. Arch. Gen. Psychiat. 17:544.CrossRefGoogle Scholar
  36. Scapagnini, U.; De Schaepdryver, A. F.; and Preziosi, P. 1969. Influence of restraint stress, corticosterone and betamethasone on brain amine levels. Pharmacol. Res. Commun. 1:63.CrossRefGoogle Scholar
  37. Schapiro, S.; Geller, E.; and Yuwiler, A. 1965/66. Differential effects of a stress on liver enzymes in adult and infant rats. Neuroendocrinology 1:138.CrossRefGoogle Scholar
  38. Shaw, D. M.; Camps, F. E.; and Eccleston, E. G. 1967. 5-Hydroxy-tryptamine in the hind-brain of depressive suicides. Brit. J. Psychiat. 113:1407.PubMedCrossRefGoogle Scholar
  39. Sourkes, T. L.; and Missala, K. 1969. Effect of yohimbine on 14CO2 production from 14C-pyrrole-ring-labeled DL-tryptophan in rats treated with L-tryptophan, DL-α-methyltryptophan and cortisol. Canad. J. Biochem. 47:1049.CrossRefGoogle Scholar
  40. Trethowan, W. H.; and Cobb, S. 1952. Neuropsychiatric aspects of Cushing’s syndrome. Arch. Neurol. Psychiat. 67:283.Google Scholar
  41. van Praag, H. M.; Korf, J.; and Puite, J. 1970. 5-Hydroxyindole-acetic acid levels in the cerebrospinal fluid of depressive patients treated with probenecid. Nature 225:1259.PubMedCrossRefGoogle Scholar
  42. van Praag, H. M., and Leijnse, B. 1963. Die Bedeutung der Monoaminoxydasenemmung als antidepressives Prinzip-I. Psychophar-macologia 4:1.CrossRefGoogle Scholar
  43. Weitzmann, E. D; Rapport, M. M.; McGregor, P.; and Jacoby, J. 1968. Sleep patterns of the monkey and brain serotonin concentration: effect of p-chlorophenylalanine. Science 160:1361.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1971

Authors and Affiliations

  • G. Curzon
    • 1
  1. 1.Institute of NeurologyLondonEngland

Personalised recommendations